Technical Analysis for ARCH - Arch Biopartners Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 1.28% | |
20 DMA Resistance | Bearish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Fell Below 20 DMA | Bearish | 0.42% |
Alert | Time |
---|---|
Boomer Buy Entry | about 8 hours ago |
Rose Above Previous Day's High | about 8 hours ago |
Outside Day | about 8 hours ago |
10 DMA Support | about 9 hours ago |
20 DMA Support | about 10 hours ago |
Get a Trading Assistant
- Earnings date: 2024-05-28
Arch Biopartners Inc Description
Arch Biopartners Inc. is a portfolio-based biotechnology company. The Company is focused on the development of technologies that make a medical or commercial impact. Its technology platforms include AB569, MetaBlok, Arch Inflammation, Borg and MetaMx. AB569 is a drug candidate for treating antibiotic resistant bacterial infections, primarily in the lungs and urinary tract. MetaBlok is a drug candidate targeting sepsis, cancer metastasis and inflammation based diseases. Arch Inflammation is a treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. Arch Inflammation is focused on developing anti-inflammatory small molecules that target proteins in the innate immune system. Borg is a peptide-solid surface Interface for binding of peptides to solid metal and plastic surfaces to inhibit biofilm formation. MetaMx are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The Company has not generated any revenues.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Metal Health Medicine Drug Biotechnology Disease Cancer Diseases Plastic Bacteria Immunology Tumor Infection Peptide Antibiotic Immune System Inflammation Proteins Biofilm Peptides Brain Brain Tumor Chronic Kidney Infections Technology Platforms
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.56 |
52 Week Low | 0.97 |
Average Volume | 30,362 |
200-Day Moving Average | 1.610 |
50-Day Moving Average | 1.946 |
20-Day Moving Average | 2.367 |
10-Day Moving Average | 2.373 |
Average True Range | 0.071 |
RSI (14) | 64.91 |
ADX | 31.72 |
+DI | 26.365 |
-DI | 16.416 |
Chandelier Exit (Long, 3 ATRs) | 2.337 |
Chandelier Exit (Short, 3 ATRs) | 2.323 |
Upper Bollinger Bands | 2.486 |
Lower Bollinger Band | 2.247 |
Percent B (%b) | 0.56 |
BandWidth | 10.074 |
MACD Line | 0.108 |
MACD Signal Line | 0.137 |
MACD Histogram | -0.0292 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.455 | ||||
Resistance 3 (R3) | 2.453 | 2.427 | 2.443 | ||
Resistance 2 (R2) | 2.427 | 2.408 | 2.428 | 2.438 | |
Resistance 1 (R1) | 2.403 | 2.396 | 2.390 | 2.405 | 2.434 |
Pivot Point | 2.377 | 2.377 | 2.370 | 2.378 | 2.377 |
Support 1 (S1) | 2.353 | 2.358 | 2.340 | 2.355 | 2.326 |
Support 2 (S2) | 2.327 | 2.346 | 2.328 | 2.322 | |
Support 3 (S3) | 2.303 | 2.327 | 2.318 | ||
Support 4 (S4) | 2.305 |